{"denoms":[{"counts":[{"groupId":"BG000","value":"51"},{"groupId":"BG001","value":"53"},{"groupId":"BG002","value":"104"}],"units":"Participants"}],"groups":[{"description":"bortezomib (Velcade) 1.6 mg/m² bolus injection on Days 1, 8, 15 and 22 every 5 weeks for 4 cycles","id":"BG000","title":"Bortezomib"},{"description":"no treatment, observation only","id":"BG001","title":"Non-treated Control"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"27","upperLimit":"75","value":"56.7"},{"groupId":"BG001","lowerLimit":"35","upperLimit":"73","value":"54.7"},{"groupId":"BG002","lowerLimit":"27","upperLimit":"75","value":"55.7"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"40"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"33"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"64"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}